Arbor Capital
510 L Street, Suite 550, Anchorage, AK, 99501, United States
Overview
Arbor Capital is an investment firm focused on venture capital and growth equity investing within the technology sector globally.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Specialty Renal Products(SRP)
Led · Series A · Sep 2018
Specialty Renal Products (SRP) is a medical device company and subsidiary of Nephros focused on products for patients with renal disease, notably a hemodiafiltration (HDF) system for ESRD. SRP's first‑generation device is currently the only FDA‑cleared HDF system in the United States. The company is developing a second‑generation HDF system and intends to use the proceeds from the financing to complete development, initial commercial production, and a planned initial launch in late 2019. SRP closed a $3 million Series A financing in September 2018 led by Wexford Capital and Arbor Capital, with participation from company management. Following the financing, parent company Nephros will retain a 62.5% equity interest in SRP. SRP is based in South Orange, New Jersey, and operates within Nephros's broader medical‑device portfolio.
Team
No current team members are available.